DrugPatentWatch Database Preview
VIEKIRA PAK (COPACKAGED) Drug Profile
When do Viekira Pak (copackaged) patents expire, and what generic alternatives are available?
Viekira Pak (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. There are eighteen patents protecting this drug.
This drug has five hundred and sixty-five patent family members in fifty-three countries.
The generic ingredient in VIEKIRA PAK (COPACKAGED) is dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir. One supplier is listed for this compound. Additional details are available on the dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir profile page.
Summary for VIEKIRA PAK (COPACKAGED)
| International Patents: | 565 |
| US Patents: | 18 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 1 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VIEKIRA PAK (COPACKAGED) |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for VIEKIRA PAK (COPACKAGED) |
| DailyMed Link: | VIEKIRA PAK (COPACKAGED) at DailyMed |
-patent-expirations.png "VIEKIRA PAK (COPACKAGED) drug patent expirations")
Generic Entry Opportunity Date for VIEKIRA PAK (COPACKAGED)
Generic Entry Date for VIEKIRA PAK (COPACKAGED)*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET, TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for VIEKIRA PAK (COPACKAGED)
| Dasabuvir / ombitasvir / paritaprevir / ritonavir |
| Dasabuvir combination with ombitasvir, paritaprevir and ritonavir |
| Ombitasvir, dasabuvir, paritaprevir, and ritonavir |
| S900006810 |
| Viekira Pak |
| Viekira Xr |
US Patents and Regulatory Information for VIEKIRA PAK (COPACKAGED)
Expired US Patents for VIEKIRA PAK (COPACKAGED)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir | TABLET, TABLET;ORAL | 206619-001 | Dec 19, 2014 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir | TABLET, TABLET;ORAL | 206619-001 | Dec 19, 2014 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for VIEKIRA PAK (COPACKAGED)
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201200950 | ➤ Try a Free Trial |
| Hong Kong | 1184068 | ➤ Try a Free Trial |
| New Zealand | 715562 | ➤ Try a Free Trial |
| Japan | 2014532627 | ➤ Try a Free Trial |
| Eurasian Patent Organization | 201170434 | ➤ Try a Free Trial |
| Denmark | 2954892 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for VIEKIRA PAK (COPACKAGED)
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2692346 | 122017000074 | Germany | ➤ Try a Free Trial | PRODUCT NAME: PIBRENTASVIR ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/17/1213 20170726 |
| 2340029 | PA2015011,C2340029 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: PARITAPREVIRAS; REGISTRATION NO/DATE: EU/1/14.982 20150115 |
| 2692346 | PA2017033,C2692346 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: PIBRENTASVIRAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/17/1213 20170726 |
| 2203431 | PA2015013 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: DASABUVIRUM; REGISTRATION NO/DATE: EU/1/14/983 20150115 |
| 2203431 | 92666 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119 |
| 2203431 | CR 2015 00014 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
